1.Haumann, J, Joosten, EBA, Everdingen, M (2017) Pain prevalence in cancer patients: Status quo or opportunities for improvement? Curr Opin Support Palliat Care 11, 99–104.
2.Breivik, H, Cherny, N, Collett, B, et al. (2009) Cancer-related pain: A pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 20, 1420–1433.
3.Shi, Q, Smith, TG, Michonski, JD, Stein, KD, Kaw, C, Cleeland, CS (2011) Symptom burden in cancer survivors 1 year after diagnosis. Cancer 117, 2779–2790.
4.Fortner, BV, Okon, TA, Portenoy, RK (2002) A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain 3, 38–44.
5.Adam, R, Wassell, P, Murchie, P (2014) Why do patients with cancer access out-of-hours primary care? A retrospective study. Br J Gen Pract 64, e99–e104.
6.Adam, R, Bond, C, Murchie, P (2015) Educational interventions for cancer pain. A systematic review of systematic reviews with nested narrative review of randomized controlled trials. Patient Educ Couns 98, 269–282.
7.Martinez, KA, Aslakson, RA, Wilson, RF, et al. (2014) A systematic review of health care interventions for pain in patients with advanced cancer. Am J Hosp Palliat Care 31, 79–86.
8.Bickel, K, Ozanne, E (2017) Importance of costs and cost effectiveness of palliative care. J Oncol Pract 13, 287–289.
10.McCaffrey, N, Cassel, JB, Coast, J (2017) An economic view on the current state of the economics of palliative and end-of-life care. Palliat Med 31, 291–292.
11.Bennett, MI, Mulvey, MR, Campling, N, et al. (2017) Self-management toolkit and delivery strategy for end-of-life pain: The mixed-methods feasibility study. Health Technol Assess 21, 1–292.
13.Serlin, RC, Mendoza, TR, Nakamura, Y, Edwards, KR, Cleeland, CS (1995) When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61, 277–84.
14.Curtis, L (2016) Unit costs of health and social care 2015: Kent: Personal Social Services Research Unit; 2016.
15.Dolan, P, Gudex, C, Kind, P, Williams, A (1995) A social tariff for EuroQol: Results from a UK general population survey. York: Centre for Health Economics University of York.
16.Rowen, D, Brazier, J, Young, T, et al. (2011) Deriving a preference-based measure for cancer using the EORTC QLQ-C30. Value Health 14, 721–731.
17.Wichmann, AB, Adang, EM, Stalmeier, PF, et al. (2017) The use of quality-adjusted life years in cost-effectiveness analyses in palliative care: Mapping the debate through an integrative review. Palliat Med 31, 306–322.
18.Al-Janabi, H, Flynn, TN, Coast, J (2012) Development of a self-report measure of capability wellbeing for adults: The ICECAP-A. Qual Life Res 21, 167–176.
19.Jensen, MP, McFarland, CA (1993) Increasing the reliability and validity of pain intensity measurement in chronic pain patients. Pain 55, 195–203.
20.Meads, DM, Marshall, A, Hulme, CT, Dunn, JA, Ford, HE (2016) The cost effectiveness of docetaxel and active symptom control versus active symptom control alone for refractory oesophagogastric adenocarcinoma: Economic analysis of the COUGAR-02 Trial. PharmacoEconomics 34, 33–42.
21.Zylla, D, Steele, G, Gupta, P (2017) A systematic review of the impact of pain on overall survival in patients with cancer. Support Care Cancer 25, 1687–1698.
22.Kroenke, K, Theobald, D, Wu, J, et al. (2010) Effect of telecare management on pain and depression in patients with cancer: A randomized trial. JAMA 304, 163–171.
23.de Wit, R, van Dam, F (2001) From hospital to home care: A randomized controlled trial of a Pain Education Programme for cancer patients with chronic pain. J Adv Nurs 36, 742–754.
24.Fenwick, E, O'Brien, BJ, Briggs, A (2004) Cost-effectiveness acceptability curves–facts, fallacies and frequently asked questions. Health Econ 13, 405–415.
25.Claxton, KP, Sculpher, MJ (2006) Using value of information analysis to prioritise health research: Some lessons from recent UK experience. PharmacoEconomics 24, 1055–1068.
27.Strong, M, Oakley, JE, Brennan, A (2014) Estimating multiparameter partial expected value of perfect information from a probabilistic sensitivity analysis sample: A nonparametric regression approach. Med Decis Making 34, 311–326.
28.Ling, CC, Lui, LY, So, WK (2012) Do educational interventions improve cancer patients' quality of life and reduce pain intensity? Quantitative systematic review. J Adv Nurs 68, 511–520.
29.Bennett, MI, Bagnall, AM, Raine, G, et al. (2011) Educational interventions by pharmacists to patients with chronic pain: Systematic review and meta-analysis. Clin J Pain 27, 623–630.
30.Santos Salas, A, Fuentes Contreras, J, Armijo-Olivo, S, et al. (2016) Non-pharmacological cancer pain interventions in populations with social disparities: A systematic review and meta-analysis. Support Care Cancer 24, 985–1000.
31.Sellick, SM, Zaza, C (1998) Critical review of 5 nonpharmacologic strategies for managing cancer pain. Cancer Prev Control 2, 7–14.
32.Jho, HJ, Myung, SK, Chang, YJ, Kim, DH, Ko, DH (2013) Efficacy of pain education in cancer patients: A meta-analysis of randomized controlled trials. Support Care Cancer 21, 1963–1971.
33.Lee, YJ, Hyun, MK, Jung, YJ, Kang, MJ, Keam, B, Go, SJ (2014) Effectiveness of education interventions for the management of cancer pain: A systematic review. Asian Pac J Cancer Prev 15, 4787–4793.
34.Marie, N, Luckett, T, Davidson, PM, Lovell, M, Lal, S (2013) Optimal patient education for cancer pain: A systematic review and theory-based meta-analysis. Support Care Cancer 21, 3529–3537.
35.Adam, R, Burton, CD, Bond, CM, De Bruin, M, Murchie, P (2017) Can patient-reported measurements of pain be used to improve cancer pain management? A systematic review and meta-analysis. BMJ Support Palliat Care 7, 0.
36.Bennett, MI, Bagnall, AM, José Closs, S (2009) How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis. Pain 143, 192–199.
37.Round, J, Jones, L, Morris, S (2015) Estimating the cost of caring for people with cancer at the end of life: A modelling study. Palliat Med 29, 899–907.
38.Gardiner, C, Ingleton, C, Ryan, T, Ward, S, Gott, M (2017) What cost components are relevant for economic evaluations of palliative care, and what approaches are used to measure these costs? A systematic review. Palliat Med 31, 323–337.
39.Meads, DM, O'Dwyer, JL, Hulme, CT, Chintakayala, P, Vinall-Collier, K, Bennett, MI (2017) Patient preferences for pain management in advanced cancer: Results from a discrete choice experiment. Patient 10, 643–651.
40.Bennett, MI, Ziegler, L, Allsop, M, Daniel, S, Hurlow, A (2016) What determines duration of palliative care before death for patients with advanced disease? A retrospective cohort study of community and hospital palliative care provision in a large UK city. BMJ Open 6, e012576.